Macomber Lori
EVP, CFO & Treasurer
Macomber Lori has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Feb 4, 2026.
On the most recent filing, Macomber Lori is listed as EVP, CFO & Treasurer at Karyopharm Therapeutics Inc. Inside the rolling window, Macomber Lori reported no open-market purchases and 1 open-market sale totaling $10K in KPTI.
Companies traded
Other insiders at KPTI
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$10K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Macomber Lori made?
Macomber Lori has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does Macomber Lori trade?
Macomber Lori has filed SEC Form 4 disclosures for 1 company, including KPTI.
When was Macomber Lori's most recent SEC Form 4 filing?
Macomber Lori's most recent SEC Form 4 filing on Tracefour is dated Feb 4, 2026.
What is Macomber Lori's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Macomber Lori is listed as EVP, CFO & Treasurer.
What is Macomber Lori's total buy and sell value in the current window?
Inside the rolling retention window, Macomber Lori bought $0 and sold $10K based on SEC Form 4 filings.
What was Macomber Lori's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,626 KPTI shares on 2026-02-03, worth $10K, per SEC Form 4 filings.